First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells.

MLA

Wu, Jun, et al. “First Case of COVID-19 Infused with HESC Derived Immunity- and Matrix-Regulatory Cells.” Cell Proliferation, vol. 53, no. 12, Dec. 2020, p. e12943. EBSCOhost, https://doi.org/10.1111/cpr.12943.

APA

Wu, J., Hu, Z., Wang, L., Tan, Y., Hou, W., Li, Z., Gao, T., Fan, J., Guo, B., Dai, H., Li, W., Hao, J., Jin, R., & Hu, B. (2020). First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells. Cell Proliferation, 53(12), e12943. https://doi.org/10.1111/cpr.12943

Chicago

Wu, Jun, Zhongjie Hu, Liu Wang, Yuanqing Tan, Wei Hou, Zhongwen Li, Tingting Gao, et al. 2020. “First Case of COVID-19 Infused with HESC Derived Immunity- and Matrix-Regulatory Cells.” Cell Proliferation 53 (12): e12943. doi:10.1111/cpr.12943.